Litigation Details for Eagle Pharmaceuticals, Inc. v. Hospira, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Eagle Pharmaceuticals, Inc. v. Hospira, Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-07-19 |
| Court | District Court, D. Delaware | Date Terminated | 2022-04-19 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | Plaintiff | Referred To | Christopher J. Burke |
| Patents | 10,010,533; 9,000,021; 9,034,908; 9,144,568; 9,572,887; 9,579,384; 9,597,397; 9,597,398; 9,597,399 | ||
| Link to Docket | External link to docket | ||
Details for Eagle Pharmaceuticals, Inc. v. Hospira, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-12-28 | 108 | Order | constructions for certain terms in U.S. Patent No. 9,572,887 (the “887 patent”), and the Court held a Markman…2018 19 April 2022 1:18-cv-01074 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document |
| 2022-04-20 | 160 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,572,887 B2; US 10,010,533 B2; US 9,034,908…2018 19 April 2022 1:18-cv-01074 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document |
| 2019-12-16 | 35 | Memorandum Opinion | 1 U.S. Patent Nos. 10,010,533 (the "#533 patent"), 9,034,908 (the "#908 patent"),…quot;#568 patent"), 9,597,397 (the "#397 patent"), 9,597,398 (the "#398 patent")…#399 patent"), 9,000,021 (the "#021 patent"), and 9,579,384 (the ·"#384 patent"… The ninth asserted patent, U.S. Patent No. 9,572,887 (the "#887 patent"), requires a "…quot;). to these patents as the "PG patents." In Counts II through IX and XI through XVIII of | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
